Agilent Technologies, Inc.
Financials
Valuation Metrics
Agilent Technologies, Inc.'s Market Cap is $39.51B. At end of 2025 it was $38.44B. Ranked #386 of 3,112 in US market (top 12%), #275 of 1,667 on NYSE (top 16%), #20 of 206 in Health Care Equipment & Services (top 10%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $39.51B | US#386/3,112 Sec#20/206 |
| Revenue | $7.23B | US#717/3,112 Sec#39/206 |
| Net Income | $1.41B | US#417/3,112 Sec#21/206 |
| Total Assets | $13.06B | US#832/3,112 Sec#39/206 |
| Net Assets | $7.12B | US#556/3,112 Sec#32/206 |
| Employees | 18,000 | US#397/3,112 Sec#36/206 |
| Value | ||
| P/E | 27.94x | US#1,391/3,112 Sec#44/206 |
| P/B | 5.55x | US#2,250/3,112 Sec#145/206 |
| PEG | 0.48x | US#556/3,112 Sec#15/206 |
| P/S | 5.46x | US#2,330/3,112 Sec#162/206 |
| EV/EBITDA | 20.93x | US#1,899/3,112 Sec#88/206 |
| FCF Yield | 3.18% | US#1,724/3,112 Sec#103/206 |
| Profitability | ||
| ROE | 19.85% | US#581/3,112 Sec#28/206 |
| ROA | 10.82% | US#397/3,112 Sec#22/206 |
| Op. Margin | 21.50% | US#819/3,112 Sec#24/206 |
| Revenue Growth | 10.01% | US#1,301/3,112 Sec#91/206 |
| Earnings Growth | 57.67% | US#515/3,112 Sec#20/206 |
| Financial Health | ||
| Debt Ratio | 83.45% | US#910/3,112 Sec#95/206 |
| Total Debt | $3.35B | US#869/3,112 Sec#39/206 |
| FCF | $1.26B | US#487/3,112 Sec#32/206 |
| Cash | $1.81B | US#453/3,112 Sec#27/206 |
| Current Ratio | 2.10x | US#1,193/3,112 Sec#111/206 |
| Net Debt/EBITDA | 0.79x | US#941/3,112 Sec#53/206 |
| Dividend | ||
| Div. Yield | 0.72% | US#1,414/3,112 Sec#37/206 |
| Div. Growth | 5.47% | US#779/3,112 Sec#29/206 |
| Performance | ||
| 1Y Return | 23.64% | US#1,403/3,112 Sec#95/206 |
| 1M Return | 6.97% | US#762/3,112 Sec#60/206 |
| From 52W High | -12.61% | US#1,237/3,112 Sec#89/206 |
| 1Y MDD | -29.75% | US#1,363/3,112 Sec#51/206 |
| Trading | ||
| Volume | 1,280,205 shares | US#1,268/3,112 Sec#81/206 |
| Trading Value | $178M | US#574/3,112 Sec#43/206 |
| Per Share | ||
| EPS | $4.56 | US#701/3,112 Sec#44/206 |
| BPS | $24.41 | US#1,042/3,112 Sec#62/206 |
Company Info
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.